Cargando…

POS-970 PREVALENCE OF SARS-CoV-2 INFECTION IN HAEMODIALYSIS PATIENTS- A RETROSPECTIVE STUDY

Detalles Bibliográficos
Autores principales:	VORA, A., Raman, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854811/ http://dx.doi.org/10.1016/j.ekir.2022.01.1010

Ejemplares similares

POS-879 PREVALENCE OF SARS-CoV-2 INFECTION IN RENAL TRANSPLANT RECIPIENTS- A RETROSPECTIVE STUDY
por: VORA, A., et al.
Publicado: (2022)

POS-973 MEASURING SERORESPONSE TO SARS-CoV-2 INFECTION AND VACCINATIONS IN HAEMODIALYSIS PATIENTS
por: Warrens, H., et al.
Publicado: (2022)

The seroprevalence of SARS-CoV-2 in patients on haemodialysis
por: Mahalingasivam, Viyaasan, et al.
Publicado: (2020)

SARS CoV-2 seropositivity in haemodialysis patients
por: Toapanta, Nestor, et al.
Publicado: (2022)

SARS-CoV-2 infection in patients with chronic kidney disease on haemodialysis. Evolution of SARS-CoV-2 CRP()
por: Zúñiga, José, et al.
Publicado: (2021)

Presentation and outcomes of SARS-CoV-2 Omicron variant infection in haemodialysis patients
por: Chimon, Alice, et al.
Publicado: (2022)

POS-005 NEUTRALIZING ANTI SARS-CoV-2 ANTIBODY RESPONSE TO COVID - 19 VACCINES: ChAdOx1-nCoV-19 AND BBV152 AMONG HAEMODIALYSIS PATIENTS
por: Selvanathan, D., et al.
Publicado: (2022)

POS-004 NEUTRALIZING ANTI SARS-CoV-2 ANTIBODY RESPONSE TO COVID-19 VACCINES: ChAdOx1-nCoV-19 AND BBV152 AMONG HAEMODIALYSIS PATIENTS
por: Selvanathan, D., et al.
Publicado: (2022)

POS-685 SARS-COV2 INFECTION IN PATIENTS ON PERITONEAL DIALYSIS
por: Bettaieb, A., et al.
Publicado: (2022)

Prolonged detection of SARS-CoV-2 RNA in chronic haemodialysis patients
por: Ribitsch, Werner, et al.
Publicado: (2021)

POS-861 INCIDENCE AND RISK FACTORS OF ACUTE KIDNEY INJURY WITH SARS-CoV-2 INFECTION IN DISADVANTAGED POPULATION
por: NAVA-VARGAS, M.G., et al.
Publicado: (2022)

Incidence of severe breakthrough SARS-CoV-2 infections in vaccinated kidney transplant and haemodialysis patients
por: Rodríguez-Espinosa, Diana, et al.
Publicado: (2022)

Distinct immune signatures discriminate between asymptomatic and presymptomatic SARS-CoV-2(pos) subjects
por: Yu, Shanhe, et al.
Publicado: (2021)

POS-887 GROSS HEMATURIA AFTER SARS-CoV-2 VACCINATION: QUESTIONNAIRE SURVEY IN JAPAN
por: AOKI, R., et al.
Publicado: (2022)

POS-134 NEW ONSET NEPHROTIC SYNDROME FOLLOWING INACTIVATED SARS-CoV-2 VACCINE
por: Lim, Y.S., et al.
Publicado: (2022)

128 days of SARS-CoV-2 viral shedding in a haemodialysis patient
por: Heylen, Line, et al.
Publicado: (2021)

Antibody response to mRNA SARS-CoV-2 vaccines in haemodialysis patients
por: Paal, Michael, et al.
Publicado: (2021)

Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients—Authors´ Reply
por: Stumpf, Julian, et al.
Publicado: (2021)

Heterogeneous neutralizing antibodies production after SARS-CoV-2 vaccination in haemodialysis patients
por: Lamy, Gaspard, et al.
Publicado: (2021)

POS-529 COVID 19 INFECTION AMONG HAEMODIALYSIS PATIENTS OF A SPECIALISED KIDNEY HOSPITAL IN BANGLADESH
por: Kashem, T.S., et al.
Publicado: (2021)

POS-037 KIDNEY INVOLVEMENT IN SARS-Co-V-2 INFECTION. A LATIN AMERICAN REGISTRY
por: Lombardi, R., et al.
Publicado: (2021)

Longevity and correlation with disease severity of the humoral and cellular response to SARS-CoV-2 infection in haemodialysis patients
por: De Vriese, An S, et al.
Publicado: (2021)

Humoral response after SARS-CoV-2 booster vaccination in haemodialysis patients with and without prior infection
por: Füessl, Louise, et al.
Publicado: (2022)

POS-961 INCREASED RISK OF EXTRACORPOREAL CIRCUIT CLOTTING IN HAEMODIALYSIS PATIENTS WITH COVID 19
por: Sudusinghe, D.H., et al.
Publicado: (2022)

Looking back over the 1 970s
Publicado: (1979)

Humoral response to SARS-CoV-2 vaccination in haemodialysis patients and a matched cohort
por: Zhao, Tianchen, et al.
Publicado: (2022)

POS-859 Recurrence or reactivation of SARS-CoV-2 infection after immunosuppressive therapy in ANCA-Associated Vasculitis with COVID-19
por: MBENGUE, M., et al.
Publicado: (2022)

POS-959 CLINICAL PROFILE AND OUTCOME OF SARS-CoV2 INFECTION IN RENAL TRANSPLANT RECIPIENTS - A SINGLE CENTRE EXPERIENCE
por: SHAJI, S., et al.
Publicado: (2022)

Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients
por: Di Gennaro, Francesco, et al.
Publicado: (2022)

Co-infection associated with SARS-CoV-2 and their management
por: Chavda, Vivek P, et al.
Publicado: (2023)

POS-085 SEVER SYMPTOMATIC HYPONATREMIA IN SETTING OF MILD SARS-COV2 INFECTION
por: BASHIR, N., et al.
Publicado: (2022)

POS-907 COVID-19 AND SARS-CoV-2 VACCINE IN HEMODIALYSIS PATIENTS. EXPERIENCE IN A GUATEMALAN CENTER
por: MAZARIEGOS, C., et al.
Publicado: (2022)

The $\delta$(970) resonance and other $O^{+}$ effects
por: Holmgren, S O
Publicado: (1977)

Production and decay properties of the $]Delta$(970) meson
por: Gay, J B, et al.
Publicado: (2000)

Rapid decline of anti-SARS-CoV-2 antibodies in patients on haemodialysis: the COVID-FRIAT study
por: Alcázar-Arroyo, Roberto, et al.
Publicado: (2021)

Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis
por: Strengert, Monika, et al.
Publicado: (2021)

POS-623 NUTRITIONAL STATUS BY SOCIOECONOMIC GROUP DURING COVID-19 PANDEMIC IN HAEMODIALYSIS PATIENTS
por: Hinostroza Yanahuaya, J., et al.
Publicado: (2022)

POS-940 ANTIBODY RESPONSE TO PFIZER BNT162b2 VACCINE IN HEMODIALYSIS PATIENTS: THE PREVIOUS SARS-CoV-2 INFECTION INFLUENCE
por: FREITAS, M., et al.
Publicado: (2022)

POS-524 MORTALITY AMONG NEW HAEMODIALYSIS PATIENTS IN THE FIRST SIX MONTHS OF COVID-19 PANDEMIC
por: HAZARA, A., et al.
Publicado: (2021)

Prevalence of Asymptomatic SARS-CoV-2 Infection in Japan
por: Suzuki, Toru, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c4rumgnhfqopjrngj9fs348g5s